- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Anaplastic thyroid cancer spheroids as preclinical models to test therapeutics ; volume:43 ; number:1 ; day:19 ; month:3 ; year:2024 ; pages:1-15 ; date:12.2024
Journal of experimental & clinical cancer research ; 43, Heft 1 (19.3.2024), 1-15, 12.2024
- Creator
-
Hu, Jiangnan
Liu, Kaili
Ghosh, Chandrayee
Khaket, Tejinder Pal
Shih, Helen
Kebebew, Electron
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-024-03009-8
- URN
-
urn:nbn:de:101:1-2405211123221.462250092445
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:52 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hu, Jiangnan
- Liu, Kaili
- Ghosh, Chandrayee
- Khaket, Tejinder Pal
- Shih, Helen
- Kebebew, Electron
- SpringerLink (Online service)
Other Objects (12)
FGF-receptors and PD-L1 in anaplastic and poorly differentiated thyroid cancer: evaluation of the preclinical rationale
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
Challenges of applying multicellular tumor spheroids in preclinical phase
Anaplastic thyroid cancer : How far can we go?
Anaplastic Thyroid Carcinoma with Ocular Then Orbital Metastases
Vascularised cardiac spheroids-on-a-chip for testing the toxicity of therapeutics
Long-term results of radiotherapy in anaplastic thyroid cancer
Therapeutic advances in anaplastic thyroid cancer: a current perspective
Anaplastic thyroid carcinoma with chondrosarcomatous differentiation: a case report
Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer
Results of combined treatment of anaplastic thyroid carcinoma (ATC)
Recent advances in the management of anaplastic thyroid cancer
FGF-receptors and PD-L1 in anaplastic and poorly differentiated thyroid cancer: evaluation of the preclinical rationale
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
Challenges of applying multicellular tumor spheroids in preclinical phase
Anaplastic thyroid cancer : How far can we go?
Anaplastic Thyroid Carcinoma with Ocular Then Orbital Metastases
Vascularised cardiac spheroids-on-a-chip for testing the toxicity of therapeutics
Long-term results of radiotherapy in anaplastic thyroid cancer
Therapeutic advances in anaplastic thyroid cancer: a current perspective
Anaplastic thyroid carcinoma with chondrosarcomatous differentiation: a case report
Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer
Results of combined treatment of anaplastic thyroid carcinoma (ATC)
Recent advances in the management of anaplastic thyroid cancer
FGF-receptors and PD-L1 in anaplastic and poorly differentiated thyroid cancer: evaluation of the preclinical rationale
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
Challenges of applying multicellular tumor spheroids in preclinical phase
Anaplastic thyroid cancer : How far can we go?
Anaplastic Thyroid Carcinoma with Ocular Then Orbital Metastases
Vascularised cardiac spheroids-on-a-chip for testing the toxicity of therapeutics
Long-term results of radiotherapy in anaplastic thyroid cancer
Therapeutic advances in anaplastic thyroid cancer: a current perspective
Anaplastic thyroid carcinoma with chondrosarcomatous differentiation: a case report
Inhibiting ERK dimerization ameliorates BRAF-driven anaplastic thyroid cancer
Results of combined treatment of anaplastic thyroid carcinoma (ATC)